On July 16, GE Healthcare announced a 10-year strategic partnership worth $500 million (approximately 3.4 billion Chinese yuan) with Catholic Health.
It is understood that Catholic Health is a non-profit healthcare system in New York operating six hospitals. This collaboration also ranks among the largest similar partnerships GE Healthcare has secured to date. Under the agreement, GE Healthcare will supply the organization with state-of-the-art imaging equipment, precision diagnosis and treatment solutions, and cutting-edge artificial intelligence technologies.
Dubbed the "Care Alliance", this partnership is expected to drive the expansion of new service lines and elevate the quality of healthcare delivery.
Under the terms of the agreement, GE Healthcare will deploy more than 1,300 new pieces of equipment across over 40 hospitals and outpatient facilities within the Catholic Health network, half of which are slated for installation within three years. The first batch of devices will be put into service in the coming months, including contrast-enhanced digital mammography, multi-modality diagnostic imaging systems, as well as maternal and infant care monitoring instruments.
It is learned that the agreement also covers multi-vendor services spanning equipment delivery, maintenance, education and training. Compared with conventional equipment procurement models, this solution will deliver greater cost efficiency for Catholic Health. The cost savings will be reinvested in technological modernization, expanded patient access to care and the development of clinical programs.
Both parties stated that this comprehensive service package is a distinctive feature that sets the Care Alliance apart from conventional equipment agreements, positioning GE HealthCare as a long-term partner supporting equipment performance and reliability across the entire healthcare system.
Beyond hardware equipment, digitalization and artificial intelligence technologies stand as core focuses of the collaboration. With the rollout of cloud-based platforms, intelligent algorithms and clinical auxiliary software suites, automated workflows will replace repetitive manual operations, substantially easing the mental and operational workload of medical staff. Take Imaging 360 as an example: this cloud-native radiology operations platform enables unified integration of imaging workflows and seamless data interoperability across multiple hospital campuses, drastically boosting the efficiency of cross-campus clinical collaboration.
In addition, GE HealthCare will provide operational and workflow support to Catholic Health’s clinical teams. One of the most distinctive offerings is embedded cardiovascular scientists, who will collaborate directly with clinicians to highlight physician perspectives, clinical insights and patient care requirements, which may serve as references for future equipment and technological development.
Records show that Catholic Health operates more than 1,900 hospital beds and employs over 17,000 staff across Long Island. According to its 2025 annual report, the integrated healthcare system posted a net revenue of $3.7 billion last year. Last December, it opened a $500 million patient care tower at its Good Samaritan University Hospital.
Thanks to this partnership, Catholic Health will expand its service lines including cardiology, oncology, neurology and women’s health. The new equipment to be delivered under the cooperation will cover a full spectrum of imaging and diagnostic devices such as CT systems, nuclear medicine equipment, X-ray units, cardiac diagnostic tools, anesthesia systems and ultrasound scanners.
Through this modernization upgrade of technologies and equipment, Catholic Health will achieve multiple objectives as follows:
▪ By rolling out advanced cardiac imaging across numerous hospitals and outpatient sites, Catholic Health’s cardiology division will enable greater local access to high-quality cardiac care.
▪ By adding MR, CT and PET systems equipped with embedded artificial intelligence solutions, the initiative will cut down delays throughout oncology care workflows and shorten the turnaround time from diagnostic imaging to treatment initiation.
▪ Expand nuclear medicine capabilities at flagship facilities including St. Francis Hospital & Heart Center and Good Samaritan University Hospital to enhance the accuracy and reliability of oncology diagnosis.
▪ Add hundreds of new ultrasound systems to boost departmental efficiency and enable clinicians to deliver rapid diagnosis during frontline clinical practices such as bedside examinations.
▪ Expand capabilities in obstetrics, gynecology and maternal-fetal medicine to advance women’s health services.
Gary Havican, Interim President, Chief Executive Officer and Chief Operating Officer of Catholic Health, commented on the partnership with GE HealthCare that the collaboration integrates the clinical expertise and service quality of its healthcare system with GE HealthCare’s cutting-edge technologies, AI-powered tools and digital capabilities. It will fully advance precision medicine, expand local access to specialty care for residents, and deliver a more streamlined and efficient clinical and working experience for both patients and care providers.
Notably, this is not the first collaboration between Catholic Health and GE HealthCare. Prior to this partnership, GE HealthCare’s proprietary PET radiotracer Flyrcado™ (flurpiridaz F 18) was deployed across Catholic Health’s facilities, boosting diagnostic accuracy and enabling the development of more personalized care plans. In April 2025, St. Francis Hospital & Heart Center became the first medical institution nationwide to conduct stress PET myocardial perfusion imaging studies using this radiotracer.
According to public data, GE HealthCare boasts a market capitalization of $20.6 billion following its spin-off and independence in 2023. After a sluggish first quarter in 2026, the company recently announced strategic adjustments to its operations and executive leadership team, including the restructuring of select business divisions.
In its core business segment, GE HealthCare has formally merged its two divisions: Imaging and Advanced Visualization Solutions (AVS), to establish a brand-new Advanced Imaging Solutions (AIS) business unit valued at $14.6 billion. This integration consolidates core product lines including CT, MR, ultrasound and image-guided therapy.
In terms of global market layout, GE HealthCare has established a new Global Markets division, with the China market set as a standalone region under the independent leadership of Weiqun Song. Given the unique characteristics of China’s market regarding volume-based procurement, localized pricing and regulatory registration pathways, this differentiated organizational arrangement underscores GE HealthCare’s commitment to deepening its footprint in China.
From an ecosystem strategy perspective, GE HealthCare is shifting its business model from pure hardware sales to value-based service delivery. Following the completion of its acquisition of Intelerad and the launch of long-term strategic cooperation frameworks such as Care Alliance, the company is accelerating the transformation of its massive global installed base of medical equipment into a unified healthcare operating system network.
Relevant industry analyses also point out that this ten-year, $500 million landmark deal further validates the emerging industry trend in healthcare shifting from standalone equipment procurement to long-term integrated strategic partnerships covering technology and full-spectrum services.
